Clinical trial
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical…
NCT01489111 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT01489111 |
|---|---|
| Title | Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. |
| Official title | Efficacy and Safety of NNC 0129-0000-1003 During Surgical Procedures in Patients With Haemophilia A |
| Acronym | pathfinder™3 |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congenital Bleeding Disorder, Haemophilia A |
| Intervention type | Drug |
| Interventions | turoctocog alfa pegol |
| Enrollment | 36 |
| Start date | Aug 3, 2012 |
| Primary completion | Dec 10, 2018 |
| Completion | Dec 10, 2018 |
| First posted | Dec 9, 2011 |
| Last update posted | Aug 10, 2020 |
| Countries | Australia, Brazil, Bulgaria, Croatia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Malaysia and 9 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: